Benzphetamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for benzphetamine hydrochloride and what is the scope of freedom to operate?
Benzphetamine hydrochloride
is the generic ingredient in two branded drugs marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, Tedor Pharm, and Pfizer, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for benzphetamine hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 9 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2,357 |
| What excipients (inactive ingredients) are in benzphetamine hydrochloride? | benzphetamine hydrochloride excipients list |
| DailyMed Link: | benzphetamine hydrochloride at DailyMed |
Pharmacology for benzphetamine hydrochloride
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for benzphetamine hydrochloride
US Patents and Regulatory Information for benzphetamine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tedor Pharm | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 040747-002 | Nov 20, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Scinopharm Taiwan | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 040578-001 | Apr 17, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 090473-001 | Sep 15, 2010 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 040714-001 | Oct 29, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | DIDREX | benzphetamine hydrochloride | TABLET;ORAL | 012427-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch